Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dems pressure Thompson on privacy

Executive Summary

Thirty-five Democrats from the House and Senate sent a letter March 20 to HHS Secretary Thompson urging implementation of privacy regs. Thompson could modify the regs during the one-year period following their adoption "when necessary in order to permit compliance," the letter states. HHS Counsel Sally Canfield said Thompson is more likely to delay implementation of the regs rather than let them take effect April 14

You may also be interested in...



Bush "Helping Hand" Rx Plan Is Gaining Support Of States, Thompson Says

President Bush's interim state-based drug plan "Immediate Helping Hand" is picking up support from some states, HHS Secretary Thompson indicated.

Bush "Helping Hand" Rx Plan Is Gaining Support Of States, Thompson Says

President Bush's interim state-based drug plan "Immediate Helping Hand" is picking up support from some states, HHS Secretary Thompson indicated.

State Block Grants Possible in 2002 If Medicare Reform Fails This Year - Tauzin

Congress will consider a state block grant drug benefit in 2002 if a Medicare reform package does not pass this year, House Energy & Commerce Committee Chairman Tauzin (R-La.) predicted during a March 22 media briefing.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel